CD274 and rectal cancer: A previous study detected unchanged expression of PD-L1 in the majority of rectal cancer patients, whereas another demonstrated downregulation of PD-L1 in NSCLC patients and indicated a poor prognosis for PD-L1-positive tumors [49].